Sarah Cannon Research Institute UK is at the forefront of clinical trials, helping to bring innovative treatments and new therapies from research into patient care. As part of HCA Healthcare UK, the Institute provides access to cutting-edge clinical trials and emerging cancer treatments, working with leading clinicians and research teams to advance personalised approaches to cancer care. With a strong focus on innovation and patient-centred research, Sarah Cannon Research Institute UK is helping to shape the future of cancer treatment and offer patients access to promising new therapies that are not yet widely available. The Sarah Cannon Research Institute has received a 'Good' Rating from the CQC.